TO COMPARE THE SAFETY AND EFFICACY OF THREE DIFFERENT, PROTON PUMP INHIBITORS OMEPRAZOLE, ESOMEPRAZOLE AND RABEPRAZOLE IN A TRIPLE DRUG REGIMEN IN PATIENTS WITH PEPTIC ULCER DISEASE IN THE ERADICATION OF H. PYLORI INFECTION
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2015, Vol 2, Issue 13
Abstract
Peptic ulcer disease continues to be issue especially due to its high prevalence in the developing world. Helicobacter pylori (H. pylori) infection associated duodenal ulcers should undergo eradication therapy. There are many regimens offered for H. pylori eradication which include triple, quadruple, or sequential therapy regimens. In our study we planned to see whether these differences in pharmacokinetic properties show any difference in the efficacy and safety parameters between treatment with omeprazole rabeprazole and esomeprazole in the triple drug regimen for eradication of H.pylori infection in peptic ulcer patients in our hospital Osmania General Hospital / Osmania Medical College, Hyderabad. MATERIALS AND METHODS: A total number of 45 patients were enrolled in the study. Patients with either sex suffering from peptic ulcer defined as ulcer crater of >2.5mm in size by endoscopy. Study Design: It was a randomized double blind, parallel and comparative study. CONCLUSION: Two weeks after triple drug treatment, H.pylori was negative in 66.7%, 73% and 80% and Rapid urease test was negative in 53%, 60% and 66% in group A, B and C respectively. Endoscopy findings showed significant reduction in size and healing of ulcers in group A, B and C. There was improvement in signs and symptoms by 53 to 80%, after 2 weeks. Hence after therapy with triple drug regimen H.pylori eradication was 66-80% and healing of ulcers was 83–100% which was higher in Rabeprazole group. At 6 weeks, there was complete relief of signs and symptoms. At the follow up of 10 weeks there was no ulcer recurrence. No adverse effects were noted in all the groups. In conclusion, Triple drug regimen had shown to eradicate H.pylori infection in the treatment of Peptic ulcer. There was healing of ulcers in all the groups which was highly significant. There was no recurrence of peptic ulcer with these regimens in all the groups. However Rabeprazole group patients became asymptomatic rapidly than other groups with better H.pylori eradication.
Authors and Affiliations
Margaret Viola J, Souris Kondaveti
Keywords
Related Articles
- EP ID EP226787
- DOI 10.18410/jebmh/2015/285
- Views 108
- Downloads 0
EVALUATION OF CLINICAL, DIAGNOSTIC AND TREATMENT OUTCOME IN ACUTE EXACERBATION OF BRONCHIECTASIS IN ADULTS
BACKGROUND Bronchiectasis is defined as “abnormal and permanent dilatation of one or more bronchi due to weakening or destruction of the muscular and elastic components of the bronchial walls.” HRCT has become the gold s...
TO STUDY THE PREVALENCE OF FATTY LIVER AND RETINOPATHY IN NEWLY DIAGNOSED CASES OF TYPE 2 DIABETES MELLITUS
BACKGROUND The epidemic of Type 2 diabetes mellitus (DM) is assuming significant proportions in developing countries such as India. Diabetics have an increased risk of developing a number of serious problems affecting he...
CARDIAC INVOLVEMENT IN CHRONIC KIDNEY DISEASE
BACKGROUND At every stage of CKD, cardiovascular disease is the leading cause of morbidity and mortality with 30 to 45% of patients advancing to cardiovascular complications. (3) The aim of the study was to evaluate the...
ATTITUDE AND PERCEPTION OF FACULTIES TOWARDS TEACHING EVIDENCE BASED MEDICINE TO PRE-CLINICAL & PARA-CLINICAL MEDICAL STUDENTS
INTRODUCTION: Evidence-based medicine (EBM) is defined as the „conscientious, explicit, and judicious use of current best evidence‟. It is an important tool for lifelong learning in medicine, and medical students can dev...
GRACE SCORE IN ASSESSING THE IN-HOSPITAL MORTALITY OF ACS AND THE EVALUATION OF RISK FACTORS
BACKGROUND In India, cardiovascular diseases account for 25% of the total deaths. The survival of patients with acute myocardial infarction has improved considerably during the past 10 years with the advent of PCI & card...